| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |